Akili, Inc.
AKLI
$0.00
Change (1 day)
$1.25
Year High
$0.19
Year Low
Categories
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Akili, Inc. (AKLI) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 300 K | -59,970,000 | 21.85 M | 80.38 M | 78.03 M |
| 2022 | 41 K | -34,135,000 | 33.88 M | 144.56 M | 141.04 M |
| 2021 | 29 K | -70,477,000 | 15.18 M | 80.94 M | 79.73 M |
| 2020 | 8 K | -15,138,000 | 125.08 M | 20.18 M | 19.16 M |
| 2019 | -39,892,000 | 125.79 M | 43.54 M | 42.25 M |